Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma
- PMID: 32484591
- PMCID: PMC7686276
- DOI: 10.1002/hed.26308
Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma
Abstract
Background: We report outcomes for patients with T2N0M0 glottic squamous cell carcinoma (SCC) treated with radiation therapy (RT).
Methods: Patients who received definitive RT for T2 glottic SCC from 2000 through 2013 were retrospectively reviewed.
Results: One hundred and thirteen patients were analyzed (median follow-up time 91 months; 85 patients received three-dimensional conformal radiotherapy [3D-CRT] and 28 received intensity-modulated radiation therapy [IMRT]). Fractionation was conventional (58%) or altered (42%); 20 patients (18%) received concurrent chemotherapy. Five-year local control was 83% for the 3D-CRT vs 81% for the IMRT group (P = .76). The ultimate locoregional control at 5 years was 100% for IMRT vs 91% for 3D-CRT (P = .1). The 5-year overall survival (OS) was 78% for 3D-CRT vs 81% for IMRT (P = .83). On multivariate analysis, younger age was the only independent predictor of improved OS (P = .0002).
Conclusions: Oncologic and survival outcomes were excellent for patients with T2N0 glottic cancer. Patients treated with IMRT and 3D-CRT had no statistically significant differences in all investigated endpoints.
Keywords: T2; larynx; outcomes; radiotherapy; survival.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
Figures





References
-
- Harwood AR, Hawkins NV, Rider WD, Bryce DP. Radiotherapy of early glottic cancer--I. Int J Radiat Oncol Biol Phys. 1979;5(4):473–476. - PubMed
-
- Harwood AR, Tierie A. Radiotherapy of early glottic cancer--II. Int J Radiat Oncol Biol Phys. 1979;5(4):477–482. - PubMed
-
- Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys. 1990;18(6):1307–1313. - PubMed
-
- Lindelov B, Lauritzen AF, Hansen HS. Stage I glottic carcinoma: an analysis of tumour recurrence after primary radiotherapy. Clin Oncol (R Coll Radiol). 1990;2(2):94–96. - PubMed
Publication types
MeSH terms
Grants and funding
- P50CA097007/NH/NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- R01 DE025248/DE/NIDCR NIH HHS/United States
- R01 CA214825/CA/NCI NIH HHS/United States
- R25 EB025787/EB/NIBIB NIH HHS/United States
- R56 DE025248/DE/NIDCR NIH HHS/United States
- P30CA016672/NH/NIH HHS/United States
- R01 CA218148/CA/NCI NIH HHS/United States
- R01 CA225190/CA/NCI NIH HHS/United States
- P50 CA097007/CA/NCI NIH HHS/United States
- R01 DE028290/DE/NIDCR NIH HHS/United States
- R01DE028290/NH/NIH HHS/United States
- 1R01CA218148/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials